Clinical trial
Intradermal Trivalent Influenza Vaccine in Young Adults, a Double-blind Randomized Controlled Trial
NCT02103023 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intradermal Trivalent Influenza Vaccine in Young Adults, a Double-blind Randomized Controlled Trial
- Lead sponsor
- The University of Hong Kong
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- November 30, 2014
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza viral infections